Search Results for: medical

Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

Ariel Fernandez, an Argentine chemist (who claims to hold the fastest-awarded PhD from Yale) and the subject of institutional investigations at multiple universities, has corrected several papers recently. What makes the moves particularly unusual — and interesting — is the stated reason for the amendments: disclaiming any funding from the National Institutes of Health for … Continue reading Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

Stem cell scientist says data in retracted paper “is not falsified or fabricated”

On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has … Continue reading Stem cell scientist says data in retracted paper “is not falsified or fabricated”

Embryonic stem cell paper retracted for fabrication

Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable. The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin. According to … Continue reading Embryonic stem cell paper retracted for fabrication

Retraction appears for stem cell researcher found to have used funds for his company’s gain

A stem cell journal is retracting a paper by Gerold Feuer, a researcher at the State University of New York (SUNY) Upstate Medical Center in Syracuse who was also found to have misused grants. The Feuer story is complicated. Heralded in 2008 for landing $6.2 million in grants from the New York Stem Cell Board, … Continue reading Retraction appears for stem cell researcher found to have used funds for his company’s gain

Big trouble in little China: Two looks at what warps scientific publishing there

The press corps has turned its attention to scientific publishing in China this week. Here’s Naomi Ching’s lede — that’s how we spell it in journalism — from Nautilus: You may have heard that Chinese researchers are not very well compensated, compared to their Western counterparts. What you might not know is that they can … Continue reading Big trouble in little China: Two looks at what warps scientific publishing there

Dental journal pulls paper for duplicate publication

Contemporary Clinical Dentistry has yanked a 2012 article on “full-mouth rehabilitation” after learning that the article had already appeared in two other publications — making the journal, in effect, Contemporaneous Clinical Dentistry. The article, “Full-mouth rehabilitation of a patient with severe attrition using the Hobo Twin-Stage Procedure,” came from a group at the Dr. R. … Continue reading Dental journal pulls paper for duplicate publication

Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

Holy Chutzpah, Batman! A team of researchers in India has retracted their 2012 paper in PLoS One on botulinum toxin for plagiarism — while blaming the journal for failing to use its “soft wares” to catch the plagiarism. The article, “Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice,” was written by a group … Continue reading Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

It’s an epidemic! Another group does the right thing, retracting neuroscience paper

As the bumper sticker says, “Regime change starts at home.” Seems to be the case with scientists these days. This month we have seen commendable instances of researchers retracting papers after identifying flaws in their own data — an outbreak of integrity that has us here at Retraction Watch applauding. (We’ve even created a new … Continue reading It’s an epidemic! Another group does the right thing, retracting neuroscience paper

What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

CHICAGO — Almost two years after editors at 18 journals agreed in March 2011 to retract 88 of former retraction record holder Joachim Boldt’s papers, 10% of them hadn’t been retracted. That’s what Nadia Elia, Liz Wager, and Martin Tramer reported here Sunday in an abstract at the Seventh International Congress on Peer Review and … Continue reading What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

Papers on potential cancer drugs retracted for image manipulation

A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation. The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin … Continue reading Papers on potential cancer drugs retracted for image manipulation